StockBeat: Markets Rise as Miserable German Data Boost QE Hopes

Investing.com  |  Author 

Published Jun 07, 2019 03:20AM ET

By Geoffrey Smith

Investing.com -- Europe’s stock markets opened higher on Friday after data showing that German economic weakness continued into the second quarter encouraged speculation that the European Central Bank may have to follow through on its hints of resuming its bond-buying program to keep the economy on track.

Germany’s statistics office Destatis said exports fell by 3.7% on the month in April, while industrial production fell 1.9% - the most in over two years - and manufacturing output fell 2.5%.

At 03:20 AM ET (0720 GMT), the benchmark Euro Stoxx 600 was up 2.1 points, or 0.6% at a two-week high of 376.12.

“This is a horrible start to the second quarter for German industry, as global trade tensions as well as temporary problems in the automotive sector and chemical industry have left their marks,” said Carsten Brzeski, an economist with ING in Frankfurt.

Separately, the Deutsche Bundesbank, Germany’s central bank, slashed its growth forecast for 2019 to 0.6% from 1.6%.

Germany’s automakers, in particular, are bracing for further trouble ahead as the U.S. prepares to levy its first import tariffs on Mexico over its perceived unwillingness to stop illegal immigration into the U.S. All of the big three names have either assembly plants on Mexico, or vital suppliers to their factories in the U.S.

U.S. Vice President Mike Pence said overnight that the U.S. still intends to impose a tariff of 5% on Mexican goods on Monday, despite an offer from Mexico to assign 6,000 police to the issue. The proposed tariffs, which have taken some 3% off the peso in little more than a week, also have negative implications for Spain’s largest banks, Banco Santander (MC:SAN) and BBVA (MC:BBVA), which have large operations there.

Elsewhere, French pharma giant Sanofi (PA:SASY) rose 3.8% on news that it has chosen Novartis’ Paul Hudson to replace Olivier Brandicourt. Hudson has been CEO of Novartis '(SIX:NOVN) pharmaceuticals unit since 2016. That helped the CAC 40 to outperform with a 0.9% rise, while Germany’s Dax and the U.K. FTSE both gained 0.6%.

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes